BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24310924)

  • 1. TLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity?
    Wardill HR; Gibson RJ; Logan RM; Bowen JM
    Int J Cancer; 2014 Dec; 135(11):2483-92. PubMed ID: 24310924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced mucosal barrier dysfunction: an updated review on the role of intestinal tight junctions.
    Wardill HR; Bowen JM
    Curr Opin Support Palliat Care; 2013 Jun; 7(2):155-61. PubMed ID: 23492816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal?
    Wardill HR; Bowen JM; Gibson RJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):627-35. PubMed ID: 23053271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury.
    Al-Dasooqi N; Wardill HR; Gibson RJ
    Pathol Oncol Res; 2014 Jul; 20(3):485-91. PubMed ID: 24424533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic options.
    Wardill HR; Gibson RJ; Van Sebille YZ; Secombe KR; Logan RM; Bowen JM
    Exp Biol Med (Maywood); 2016 Jul; 241(13):1386-94. PubMed ID: 27037276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity.
    Wardill HR; Van Sebille YZ; Mander KA; Gibson RJ; Logan RM; Bowen JM; Sonis ST
    Cancer Treat Rev; 2015 Feb; 41(2):122-8. PubMed ID: 25512119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
    Cario E
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption.
    Smith JM; Dornish M; Wood EJ
    Biomaterials; 2005 Jun; 26(16):3269-76. PubMed ID: 15603822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of toll-like receptor 4 (TLR4)-mediated interleukin-6 (IL-6) production in chemotherapy-induced mucositis.
    Khan S; Wardill HR; Bowen JM
    Cancer Chemother Pharmacol; 2018 Jul; 82(1):31-37. PubMed ID: 29845394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C zeta.
    Wu LL; Chiu HD; Peng WH; Lin BR; Lu KS; Lu YZ; Yu LC
    Crit Care Med; 2011 Sep; 39(9):2087-98. PubMed ID: 21552122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms.
    Wardill HR; Gibson RJ; Van Sebille YZ; Secombe KR; Coller JK; White IA; Manavis J; Hutchinson MR; Staikopoulos V; Logan RM; Bowen JM
    Mol Cancer Ther; 2016 Jun; 15(6):1376-86. PubMed ID: 27197307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C enhances tight junction barrier function of human nasal epithelial cells in primary culture by transcriptional regulation.
    Koizumi J; Kojima T; Ogasawara N; Kamekura R; Kurose M; Go M; Harimaya A; Murata M; Osanai M; Chiba H; Himi T; Sawada N
    Mol Pharmacol; 2008 Aug; 74(2):432-42. PubMed ID: 18477669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The forskolin-induced opening of tight junctions in Xenopus gallbladder epithelium is mediated by protein kinase C.
    Kottra G; Vank C
    Cell Mol Biol (Noisy-le-grand); 2003 Feb; 49(1):33-43. PubMed ID: 12839335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells.
    Beutheu S; Ghouzali I; Galas L; Déchelotte P; Coëffier M
    Clin Nutr; 2013 Oct; 32(5):863-9. PubMed ID: 23428392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
    Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
    Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactobacillus plantarum inhibits intestinal epithelial barrier dysfunction induced by unconjugated bilirubin.
    Zhou Y; Qin H; Zhang M; Shen T; Chen H; Ma Y; Chu Z; Zhang P; Liu Z
    Br J Nutr; 2010 Aug; 104(3):390-401. PubMed ID: 20412608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARgamma agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells.
    Ogasawara N; Kojima T; Go M; Ohkuni T; Koizumi J; Kamekura R; Masaki T; Murata M; Tanaka S; Fuchimoto J; Himi T; Sawada N
    Pharmacol Res; 2010 Jun; 61(6):489-98. PubMed ID: 20227502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of toll-like receptor-4 downregulates protein kinase C-zeta and attenuates liver injury in experimental pancreatitis.
    Peng Y; Sigua CA; Rideout D; Murr MM
    Surgery; 2008 May; 143(5):679-85. PubMed ID: 18436016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4 increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis.
    Li X; Wang C; Nie J; Lv D; Wang T; Xu Y
    Alcohol; 2013 Sep; 47(6):459-65. PubMed ID: 23871536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research on intestinal tight junction barrier dysfunction should be emphasized in burn injury].
    Wang FJ
    Zhonghua Shao Shang Za Zhi; 2010 Oct; 26(5):331-3. PubMed ID: 21162780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.